Praetego, Inc.
Pharmaceutical company · Durham, North Carolina, United States
Praetego, Inc. is a pharmaceutical company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2017. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.8 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $412,703 sold in a notice filed in 2021.
Praetego at a glance
What does Praetego do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $5.8 million in total (2018 to 2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, National Eye Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $412,703 sold (2021).
Frequently asked questions about Praetego
Where is Praetego headquartered?
Praetego, Inc. is headquartered in Durham, North Carolina, United States.
What does Praetego do?
Praetego, Inc. is a pharmaceutical company.
When was Praetego founded?
The earliest incorporation on record for Praetego, Inc. is in 2017, according to public company registers.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
- G1 Therapeutics, Inc.Durham, North Carolina, United States
- Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences